Compare · ARDT vs PACS
ARDT vs PACS
Side-by-side comparison of Ardent Health Inc. (ARDT) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ARDT and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- PACS is the larger of the two at $6.70B, about 4.4x ARDT ($1.53B).
- Over the past year, ARDT is down 14.7% and PACS is up 265.5% - PACS leads by 280.2 points.
- ARDT has been more active in the news (6 items in the past 4 weeks vs 5 for PACS).
- ARDT has more recent analyst coverage (18 ratings vs 6 for PACS).
PerformanceARDT-14.67%PACS+265.50%
2025-09-02+0.00%2026-08-31
- Company
- Ardent Health Inc.
- PACS Group Inc.
- Price
- -
- -
- Market cap
- $1.53B
- $6.70B
- 1M return
- +1.31%
- -8.07%
- 1Y return
- -14.67%
- +265.50%
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- 2024
- News (4w)
- 6
- 5
- Recent ratings
- 18
- 6
Latest ARDT
- SEC Form 144 filed by Ardent Health Inc.
- Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
- SEC Form 144 filed by Ardent Health Inc.
- SEC Form 144 filed by Ardent Health Inc.
- SEC Form 144 filed by Ardent Health Inc.
- SEC Form 10-Q filed by Ardent Health Inc.
- Ardent Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Ardent Health Reports Second Quarter 2026 Results
- Ardent Health surpasses 1 million patient encounters supported by ambient AI
- Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date
Latest PACS
- Director Hancock Mark gifted 88,000 shares, decreasing direct ownership by 0.16% to 53,818,884 units (SEC Form 4)
- Director Conway Patrick Hugh sold $155,302 worth of shares (3,497 units at $44.41), decreasing direct ownership by 28% to 8,947 units (SEC Form 4)
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $6,611,433 worth of shares (150,550 units at $43.92) as part of a pre-agreed trading plan, decreasing direct ownership by 0.27% to 54,694,866 units (SEC Form 4)
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $10,437,434 worth of shares (236,116 units at $44.20) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 54,845,416 units (SEC Form 4)
- President & COO Jergensen Joshua sold $1,823,689 worth of shares (40,000 units at $45.59) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,536,320 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by PACS Group Inc.
- PACS Group, Inc. Reports Second Quarter 2026 Results
- PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by PACS Group Inc.
- PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call